D Ahern1, C M Lloyd, D S Robinson. 1. Leukocyte Biology Section, National Heart and Lung Institute, Imperial College London, London, UK.
Abstract
BACKGROUND: Allergic inflammation is associated with Th2-type T cells, which can be suppressed by CD4+ CD25+ regulatory T cells (Tregs). Both express chemokine receptors (CCR) 4 and CCR8, but the dynamics of expression and effect of atopic status are unknown. OBJECTIVE: To examine the expression of chemokine receptors by CD4+ CD25+ and CD4+ CD25- T cells from atopic and nonatopic donors, and document response to allergen stimulation in vitro. METHODS: Chemokine receptor expression was examined by flow cytometry and quantitative PCR of CD4+ CD25hi and CD4+ CD25- T cells from atopics and nonatopics. Responsiveness to chemokines was by actin polymerization. Dynamics of chemokine receptor expression in 6-day allergen-stimulated cultures was analysed by carboxyfluoroscein succinimidyl ester labelling. RESULTS: CD4+ CD25hi Tregs preferentially expressed CCR3, CCR4, CCR5, CCR6 and CCR8. CD4+ CD25hi Tregs responded to the chemokine ligands for CCR4, CCR6 and CCR8 (CCL17, 22, 20 and 1 respectively), with no differences between atopic and nonatopic donors. Over 6-day allergen stimulation, CD4+ CD25+ T-cells downregulated CCR4 and upregulated CCR7, in contrast to CD4+ CD25- effector cells, which downregulated CCR7 and upregulated CCR4. CONCLUSIONS: CCR4, CCR6 and CCR8 have potential roles in localization of both CD4+ CD25+ regulatory and CD4+ CD25- effector T cells to sites of allergic inflammation. Upregulation of CCR7 and downregulation of CCR4 upon allergen stimulation of Tregs may allow their recirculation from sites of inflammation, in contrast to retention of effector T cells.
BACKGROUND:Allergic inflammation is associated with Th2-type T cells, which can be suppressed by CD4+ CD25+ regulatory T cells (Tregs). Both express chemokine receptors (CCR) 4 and CCR8, but the dynamics of expression and effect of atopic status are unknown. OBJECTIVE: To examine the expression of chemokine receptors by CD4+ CD25+ and CD4+ CD25- T cells from atopic and nonatopic donors, and document response to allergen stimulation in vitro. METHODS:Chemokine receptor expression was examined by flow cytometry and quantitative PCR of CD4+ CD25hi and CD4+ CD25- T cells from atopics and nonatopics. Responsiveness to chemokines was by actin polymerization. Dynamics of chemokine receptor expression in 6-day allergen-stimulated cultures was analysed by carboxyfluoroscein succinimidyl ester labelling. RESULTS:CD4+ CD25hi Tregs preferentially expressed CCR3, CCR4, CCR5, CCR6 and CCR8. CD4+ CD25hi Tregs responded to the chemokine ligands for CCR4, CCR6 and CCR8 (CCL17, 22, 20 and 1 respectively), with no differences between atopic and nonatopic donors. Over 6-day allergen stimulation, CD4+ CD25+ T-cells downregulated CCR4 and upregulated CCR7, in contrast to CD4+ CD25- effector cells, which downregulated CCR7 and upregulated CCR4. CONCLUSIONS:CCR4, CCR6 and CCR8 have potential roles in localization of both CD4+ CD25+ regulatory and CD4+ CD25- effector T cells to sites of allergic inflammation. Upregulation of CCR7 and downregulation of CCR4 upon allergen stimulation of Tregs may allow their recirculation from sites of inflammation, in contrast to retention of effector T cells.
Authors: Iñigo Goya; Ricardo Villares; Angel Zaballos; Julio Gutiérrez; Leonor Kremer; José-Angel Gonzalo; Rosa Varona; Laura Carramolino; Alfredo Serrano; Pilar Pallarés; Luis Miguel Criado; Roland Kolbeck; Miguel Torres; Anthony J Coyle; José-Carlos Gutiérrez-Ramos; Carlos Martínez-A; Gabriel Márquez Journal: J Immunol Date: 2003-02-15 Impact factor: 5.422
Authors: D S Robinson; Q Hamid; S Ying; A Tsicopoulos; J Barkans; A M Bentley; C Corrigan; S R Durham; A B Kay Journal: N Engl J Med Date: 1992-01-30 Impact factor: 91.245
Authors: Chan D Chung; Frederick Kuo; Jeffrey Kumer; Alykhan S Motani; Christopher E Lawrence; William R Henderson; Chandrasekar Venkataraman Journal: J Immunol Date: 2003-01-01 Impact factor: 5.422
Authors: Eleanor M Ling; Trevor Smith; X Dao Nguyen; Carol Pridgeon; Margaret Dallman; Justine Arbery; Victoria A Carr; Douglas S Robinson Journal: Lancet Date: 2004-02-21 Impact factor: 79.321
Authors: Laura Rivino; Mara Messi; David Jarrossay; Antonio Lanzavecchia; Federica Sallusto; Jens Geginat Journal: J Exp Med Date: 2004-09-20 Impact factor: 14.307
Authors: G Banfield; H Watanabe; G Scadding; M R Jacobson; S J Till; D A Hall; D S Robinson; C M Lloyd; K T Nouri-Aria; S R Durham Journal: Allergy Date: 2010-02-10 Impact factor: 13.146
Authors: Maria Fernanda de Souza Costa; Raquel de Souza-Martins; Mariana C de Souza; Cláudia F Benjamim; Bruno Piva; Bruno L Diaz; Marc Peters-Golden; Maria das Graças Henriques; Cláudio Canetti; Carmen Penido Journal: J Leukoc Biol Date: 2009-10-30 Impact factor: 4.962
Authors: Aleena Syed; Marco A Garcia; Shu-Chen Lyu; Robert Bucayu; Arunima Kohli; Satoru Ishida; Jelena P Berglund; Mindy Tsai; Holden Maecker; Gerri O'Riordan; Stephen J Galli; Kari C Nadeau Journal: J Allergy Clin Immunol Date: 2014-02 Impact factor: 10.793
Authors: Francoise Bachelerie; Adit Ben-Baruch; Amanda M Burkhardt; Christophe Combadiere; Joshua M Farber; Gerard J Graham; Richard Horuk; Alexander Hovard Sparre-Ulrich; Massimo Locati; Andrew D Luster; Alberto Mantovani; Kouji Matsushima; Philip M Murphy; Robert Nibbs; Hisayuki Nomiyama; Christine A Power; Amanda E I Proudfoot; Mette M Rosenkilde; Antal Rot; Silvano Sozzani; Marcus Thelen; Osamu Yoshie; Albert Zlotnik Journal: Pharmacol Rev Date: 2013-11-11 Impact factor: 25.468